Clinical Trial Update: Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing the immune response to a Toll-Like Receptor 9 agonist adjuvanted pneumococcal vaccine in HIV-infected adults, which has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TLR9-agonist adjuvanted pneumococcal vaccine

Snippet

Sponsor: University of Aarhus | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED